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Abstract
The purposes of this study were to: (1) estimate the prevalence of HIV in sexually transmitted disease (STD) clinic
populations; (2) assess risk exposure categories associated with HIV seropositivity; (3) monitor trends; and (4)
supply data to inform and evaluate HIV prevention programs. Blood specimens were obtained from clients having
routine serology at their initial visit for a new disease episode. Four clinics in Miami-Dade County participated in
the 1990-1999 unlinked (blinded) seroprevalence survey. Specimens routinely collected for other purposes were
stripped of identifiers and tested for antibodies to HIV-1. Demographic and risk information was gathered before
testing. Tests results and data collection forms were forwarded to the Miami-Dade County Health Department
(MDCHD), where they were scanned and entered into a database. We analyzed data from 41,354 specimens in
relation to demographics, selected STDs, and HIV risk exposure categories. Overall HIV seroprevalence was 7.5%
with a significantly higher infection rate for men (8.3%) compared to women (6%). Among those reporting
heterosexual contact as their only risk, the infection rate (4.9%) was 13 times the estimated national HIV infection
rate (0.36%). HIV rates declined over nine years (from 10.8% to 5.8%) with significant downward trends observed
for men and women; and for whites, blacks, and Hispanics. We found a significantly higher HIV rate for ulcerative
STDs (9.4%) compared with non-ulcerative STDs (6.2%) for both males and females. Higher HIV rates were also
found among those diagnosed with multiple STDs (15.4%) compared to those in either the ulcerative or nonulcerative STD category. In conclusion, we strongly emphasize the need for assessing HIV infection in STD
patients, and STD infections in HIV-infected patients.
Florida Public Health Review, 2005; 2: 73-81
Introduction
Since the beginning of the AIDS epidemic, the
incidence of HIV/AIDS has been strongly associated
(Fleming & Wasserheit, 1999) with the co-occurrence
of other sexually transmitted diseases (STDs). There
are an estimated 19 million new cases of STDs
(Weinstock, Berman, & Cates, 2004) and 40,000 new
HIV infections (Centers for Disease Control and
Prevention [CDC], 2002) each year in the United
States. The CDC (2004) estimates that 850,000950,000 Americans are currently infected with HIV.
The presence of STDs increases the likelihood
of non-infected persons acquiring HIV infection
through sexual contact and of HIV-infected persons
transmitting HIV to sexual partners (CDC, 1998).
Furthermore, sub-populations at increased risk for HIV
transmission typically have higher rates of STDs (e.g.,
men who have sex with men (MSM) exhibit elevated
rates of bacterial and other STDs) (CDC, 2002a).
According to the Miami-Dade County Health
Department (MDCHD, 2005), male-to-male sexual
contact represented 53% of reported HIV cases among
men in the year 2004.
In 1987, the CDC conducted an extensive
review of the available information on HIV prevalence
rates in the U.S., and realized that the lack of
standardized information by demographic subgroups
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and geographic areas made those rates difficult to
interpret. During 1988-1989 the CDC in collaboration
with state and local health departments, implemented a
national serosurveillance system for HIV infection.
This surveillance system was part of the CDC family of
HIV seroprevalence surveys. It used a standardized
survey and HIV serologic testing procedures in several
metropolitan areas throughout the U.S. (Pappaioanou,
Dondero, Petersen, Onorato, Sanchez, & Currant,
1990). The present study analyzes HIV seroprevalence
data for nine years of the CDC survey (CDC, 1990)
conducted by the Miami-Dade County Health
Department (MDCHD) for the period 1990-1999. Data
collected from four public STD clinics located in
Miami-Dade County were examined in relation to client
demographics, selected STDs, and self-reported HIV
risk exposure categories.
Methods
The objectives of the STD Clinic Survey were
to: estimate the prevalence of HIV in STD clinic
populations; assess risk exposure categories associated
with HIV seropositivity in these groups; monitor trends
in infection levels and risk exposure categories over
time; and supply data to inform and evaluate HIV
prevention programs (CDC, 1990).
73
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Survey Sites
In Miami, four STD clinics were selected based
on meeting the following criteria: providing STD
services, client caseload greater than 25 per day, client
diversity, currently conducting HIV/AIDS health
education/risk reduction and offering HIV testing to all
patients seeking STD services, and expressed
willingness to participate and conduct annual surveys
(CDC, 1990).
The predominant racial/ethnic
composition of the zip code where the clinics were
located is: Clinic 1, Hispanic; Clinic 2, white nonHispanic; Clinic 3, black non-Hispanic; and Clinic 4,
Hispanic.
Participants
Clients were eligible for inclusion in the survey
at their initial visit for a new disease episode if they had
not visited the clinic since initiation of the annual survey
and had blood drawn for routine purposes. Clients were
excluded from the survey if they were: (1) returning for
follow-up visits for previously-diagnosed disease
episodes in the survey period or (2) attending the STD
clinics solely for reasons of HIV testing and counseling,
or only for evaluation or treatment of HIV infection. A
client could be included in the survey if he/she presented
for treatment of a STD and also had AIDS or HIV
infection (CDC, 1990).
Unlinked Surveys
Methodological studies have demonstrated that
participation rates for linked (confidential) surveys are
generally lower for persons who know--or strongly
suspect--that they are HIV infected, thereby causing the
observed infection rate to be biased downward.
“Unlinked” (blinded) surveys were devised to minimize
this source of bias in the estimation of HIV
seroprevalence. Individuals were not informed that
their sera would be analyzed for the presence of HIV.
Rather, sera that were collected for routine diagnostic
tests were tested for HIV antibodies after personal
identifiers were removed and replaced with a unique
survey number. Neither the HIV test results, nor the
information obtained from medical records could be
linked to specific persons; hence, the term “unlinked”
(CDC, 1990).
Data Analysis
For each eligible client, information routinely
gathered during the initial visit was used to complete
the data collection form. This form consisted of three
parts: (1) A laboratory report form containing the
survey number and response grids for serologic test
results (enzyme-linked immunosorbent assay,
immunofluorescent assay, and Western blot); (2) A set
of peel-off labels, each with the unique survey number
used to code serologic specimens; and (3) A “Sexually
Transmitted Disease Clinic Seroprevalence Survey”
form to record date, sex, age, race/ethnicity, risk
exposure, reason for clinic visit, HIV test history, and
STD diagnosis (CDC, 1990).
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The data collection form was designed to be
read by an electronic mark-sense scanner located at the
MDCHD AIDS Program Office. Attached to the data
collection form was a strip of labels bearing the same
unique identification code as on the form itself. These
labels were affixed to the blood collection tubes and
laboratory results were reported using the identification
code (CDC, 1990). Laboratory results and data
collection forms were regularly forwarded to the
MDCHD, where they were scanned and entered into a
database. Data were then sent monthly to the Florida
Department of Health Bureau of HIV/AIDS, for editing,
analysis, and transmittal to the CDC.
Chi-square tests were performed to examine
differences in proportions, differences in HIV
seroprevalence rates, and linear time trends using EpiInfo 2000 Version 1.1 software (Dean, 1999).
Results
From January 1990 through December 1999,
41,354 unlinked serologic specimens were tested for
HIV and 3,100 (7.5%) of these were HIV seropositive.
Race / Ethnicity
Among the 41,354 specimens analyzed,
25,919 (62.7%) were from black non-Hispanic clients,
11,307 (27.3%) were from Hispanic clients, 3,939
(9.5%) were from white non-Hispanic clinic attendees,
and 189 (0.5%) were not classified by race/ethnicity.
This racial distribution is representative of the STD
clinic clientele, but diverges from the Miami-Dade
County population distribution at the time of study:
approximately 12% black non-Hispanic, 52% Hispanic,
30% white non-Hispanic, and 6% other race. Overall,
similar HIV seroprevalence rates were found for
specimens from white non-Hispanics (7.7%) and black
non-Hispanics (8.0%). The white non-Hispanic rate
was significantly higher than the rate for Hispanics
(6.3%, p=0.001). However, when analyzed by site, site
1 and site 2 presented significantly higher HIV
seroprevalence rates for black non-Hispanics than for
whites (p<0.0001). In site 3, we found a higher
seroprevalence rate for white non-Hispanics than for
black non-Hispanics (p=0.008).
No significant
differences in HIV rates were found by race/ethnicity in
site 4.
Gender
HIV seroprevalence for 27,333 specimens
from men (8.3%) was significantly higher than the
corresponding rate for specimens from 14,021 women
(6%, p<0.0001). This gender disparity was found for
white non-Hispanics and Hispanics, but not for black
non-Hispanics. White non-Hispanic males reported the
highest seroprevalence rate (9.6%), when compared
with Hispanic males (8.1%, p=0.016), and black nonHispanic males (8.2%, p=0.01). For specimens from
women, a highly significant (p<0.0001) rate difference
was observed when comparing those from black women
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(7.7%) to those from white non-Hispanic women
(3.7%) and Hispanic women (2.7%). When analyzed by
site, statistically significant differences were found in
sites 1 and 2 when comparing black non-Hispanic to
white non-Hispanic and Hispanic men and women. In
site 3, white men presented a higher HIV rate than
black non-Hispanic (p=0.0009) men. In site 4, black
non-Hispanics had the highest HIV seroprevalence rate
among women. No other significant differences were
noted.
Age
The highest HIV rate was observed for the age
range 40-44 (13%). This rate was significantly higher
than for those <15 (3.7%, p<0.0001), 15-19 (1.7%), 2024 (3.1%), 25-29 (7.3%), and >45 (9%) (p<0.0001 for
all comparisons). Significantly higher seroprevalence
was observed for males compared with females in these
age groups: 35-39 (p=0.001), 40-44 (p<0.0001), and
>45 (p<0.0001). In the age group 40-44, the rate for
males (15%) was almost twice the rate for females
(8.1%). In persons 45 and older, the rate for males
(10.8%) was almost three times the rate for females
(4%).
When we analyzed the data by site, we also
found the highest HIV rate in the 40-44 age group at
sites 1 and 2. These were significantly higher than all
age ranges, excluding the 35-39 age group. The highest
HIV seroprevalence rate in site 3 was found in two age
categories: 35-39 and 40-44 years old (9.3%). These
were significantly higher than age ranges: 15-19, 20-24,
and 25-29. Site 4 presented the highest HIV rate in the
age category 35-39 (14.3%) a rate significantly higher
than in the 15-19, 20-24, and > 45 age groups.
Significantly higher seroprevalence was observed for
males compared with females in these age groups: 2529 (p=0.01), 35-39 (p=0.035), 40-44, and >45
(p<0.0001) at site 1. Findings were similar for the age
group 45 and older at site 2; and for the age ranges 2024, 40-44, and 45 and older at site 3. Significantly
higher HIV rates were also found for males compared
to females in the age groups 25-29, 30-34, 35-39, and
>45 at site 4.
All episodes were grouped into six sexually
transmitted disease (STD) diagnosis categories. The
first two categories included “ulcerative STDs” and
“non-ulcerative STDs.” The next two categories were
“STD contact” (includes all episodes when the client
reported sexual contact with a person known to have an
STD, was epi-treated, but reported no personal
diagnosis of STD), and “no info/unknown.” The last
two categories were “other” (includes any other STD
diagnosis not included above), and “multiple STDs”
(includes each visit or episode when the client was
diagnosed with two or more specific or presumptive
STDs).
We found a significantly higher HIV rate for
ulcerative STDs (9.4%) compared with non-ulcerative
Florida Public Health Review, 2005; 2: 73-81
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STDs (6.2%, p<0.0001) for both males and females.
Higher HIV rates (p<0.0001) were found in the
multiple STD category (15.4%) compared to the
ulcerative and non-ulcerative categories. Again, this
difference was significant for both males and females.
The multiple STD category was associated with the
highest seroprevalence rates for all age groups except
<15 years (ulcerative category had the highest HIV
rate).
Among all the HIV-seropositive episodes for
women, we found that 34 (97%) of the genital ulcers,
28 (88%) of STD contacts only, 124 (83%) of the
vaginal infections, 127 (88%) of the cases of syphilis,
and 103 (85%) of the multiple STD diagnoses were
reported among black-non-Hispanic women. With
respect to diagnoses, black non-Hispanic men
accounted for 226 (57%) of gonorrhea, 96 (60%) of
non-gonococcal urethritis (NGU), 201 (62%) of
syphilis, and 130 (58%) of the multiple STD diagnoses.
All episodes were grouped into nine HIV risk
exposure categories. According to CDC guidelines, the
category “sexual contact/unknown risk” included the
following risk exposure subcategories: heterosexual,
received money/drugs for sex, gave money/drugs for
sex, and smoked crack cocaine since 1978. For
comparison and analytical purposes we treated
“heterosexual contact only” as a separate category.
Among the 3,100 HIV-seropositive episodes,
1511 (48.7%) were classified as heterosexual contact
only, 618 (19.9%) were men who reported sex with
men and sex with men and women (MSM/Bisexual),
and 532 (17.1%) were classified as sexual
contact/unknown risk. The remaining episodes
included: 310 (10%) heterosexual partners of persons
with a known risk for HIV, 109 (3.5%) injection drug
users (IDUs), 20 (0.6%) MSM/Bisexual/IDUs, and 8
(0.2%) recipients of blood or blood products.
Heterosexual contact was the most commonly
reported exposure. Among 27,333 men, 19,374
(70.8%) reported heterosexual contact only, while a
significantly higher proportion of women reported this
exposure (11,530 of 14,021, 82.2%, p<0.0001). HIV
seroprevalence rates for these 19,374 men (5.1%) and
11,530 women (4.5%) also were significantly different
(p=0.018). Whereas these rates exceed the 1997
estimated HIV infection rate in the adult/adolescent
population of Miami-Dade County (25,600 HIV
seropositive/2.0 million=1.3%), they serve as baseline
seroprevalence rates for comparing infection rates for
all other identified risk exposure categories.
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Table 1. HIV Seroprevalence among STD clinic clients by site, gender and race/ethnicity
Miami/Dade County, Florida, 1990-1999
SITE
1

White

Black

Hispanic

Other

All races

SITE
2

SITE
3

SITE
4

ALL
SITES

Number

HIV+

Rate

Number

HIV+

Rate

Number

HIV+

Rate

Number

HIV+

Rate

Number

HIV+

Rate

Male

807

59

7.31

264

8

3.03

494

44

8.9

1117

147

13.16

2682

258

9.61

Female

401

17

4.23

155

8

5.16

250

8

3.2

451

14

3.1

1257

47

3.73

Subtotal

1208

76

6.29

419

16

3.81

744

52

6.98

1568

161

10.26

3939

305

7.74

Male

8311

798

9.6

2343

212

9.04

5628

300

5.33

693

74

10.67

16975

1384

8.15

Female

4526

448

9.89

978

107

10.94

3096

118

3.81

344

20

5.81

8944

693

7.74

Subtotal

12837

1246

9.7

3321

319

9.6

8724

418

4.79

1037

94

9.06

25919

2077

8.01

Male

4510

370

8.2

951

37

3.89

734

48

6.53

1349

157

11.63

7544

612

8.11

Female

2628

67

2.54

234

11

4.7

369

8

2.16

532

16

3

3763

102

2.71

Subtotal

7138

437

6.12

1185

48

4

1103

56

5.07

1881

173

9.19

11307

714

6.31

Male

93

3

3.22

7

1

14.28

15

0

0

17

0

0

132

4

3.03

Female

34

0

0

1

0

0

11

0

0

11

0

0

57

0

0

Subtotal

127

3

2.36

8

1

12.5

26

0

0

28

0

0

189

4

2.12

Male

13721

1230

8.96

3565

258

7.23

6871

392

5.7

3176

378

11.9

27333

2258

8.26

Female

7589

532

7.01

1368

126

9.21

3726

134

3.59

1338

50

3.73

14021

842

6

Total

21310

1762

8.26

4933

384

7.78

10597

526

4.96

4514

428

9.48

41354

3100

7.49
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Table 2. HIV Seroprevalence among STD Clinic Clients by Selected Sexual Transmitted Diseases and Gender
Miami/Dade County, Florida, 1990-1999
Males
Number

Females

Total

HIV+

Rate/100

Number

HIV+

Rate/100

Number

HIV+

Rate/100

Ulcerative STDs
Syphilis

2260

324

14.3

1412

146

10.3

3672

470

12.8

Genital Ulcers/Herpes

6184

470

7.6

509

35

6.9

6693

505

7.5

Genital Warts

102

6

5.9

47

4

8.5

149

10

6.7

8546

800

9.4

1968

185

9.4

10514

985

9.4

Gonorrhea

5033

397

7.9

1195

64

5.4

6228

461

7.4

NGU/cervicitis/chlamydia

2486

161

6.5

949

43

4.5

3435

204

5.9

0

0

0.0

3407

150

4.4

3407

150

4.4

Sub-total
Non-ulcerative STDs

PID

238

15

0.0

136

10

7.4

374

25

6.7

Sub-total

Penile/vaginal discharge

7757

573

7.4

5687

267

4.7

13444

840

6.2

Other STDs

3952

315

8.0

2333

154

6.6

6285

469

7.5

STD Contact

1822

113

6.2

938

32

3.4

2760

145

5.3

No Info/Unknown

3933

233

5.9

2178

83

3.8

6111

316

5.2

Multiple STDs

1323

224

16.9

917

121

13.2

2240

345

15.4

27333

2258

8.3

14021

842

6.0

41354

3100

7.5

Total
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Table 3. HIV Seroprevalence among STD Clinic Clients by Risk Exposure Categories and Gender
Miami/Dade County, Florida, 1990-1999
Male
MSM/Bisexual
IDU

Female

Total

Number

HIV+

Rate

Number

HIV+

Rate

Number

HIV+

Rate

2,217

618

27.9

0

0

0.0

2,217

618

27.9

316

70

22.2

178

39

21.9

494

109

22.1

52

20

38.5

0

0

0.0

52

20

38.5

1,431

165

11.5

1,091

136

12.5

2,522

301

11.9

68

4

5.9

48

4

8.3

116

8

6.9

2

0

0.0

0

0

0.0

2

0

0.0

3,851

390

10.1

1,132

142

12.5

4,983

532

10.7

22

1

4.5

42

0

0.0

64

1

1.6

Heterosexual contact only

19,374

990

5.1

11,530

521

4.5

30,904

1,511

4.9

Total

27,333

2,258

8.3

14,021

842

6.0

41,354

3,100

7.50

MSM/Bisexual/IDU
Heterosexual, partner at risk
HIV
Blood Recipient*
Hemophilia*
Sexual contact/unknown risk
Undetermined*

* No significant P value for comparison of the risk specific seroprevalence rate to the baseline
heterosexual contact risk-only rate
compared with clients of all other race/ethnicities.
These risks included gay/bisexual male, IDU, and
For both sexes combined, and excluding blood
sexual contact/unknown risk. Compared with all other
recipient, hemophilia, and the undetermined category,
highly significant elevations of HIV seroprevalence
races, significantly (p<0.0001) higher proportions of
above the heterosexual-contact-only baseline rate were
black non-Hispanics reported engaging in four
found for each of the exposure categories. Moreover,
behavioral risks: gay/bisexual, IDU, heterosexual
statistically significant differences between men and
partner at risk of HIV, and sexual contact/unknown
women were found for all of the risk exposure
risk.
categories for which seropositivity rates were available
A highly significant decline in HIV infection
for both sexes, with the exception of the IDU category
rates was observed across the nine full-year annual
(p=0.95).
cycles of data collection (see Figure 1), from 10.83% in
A significantly higher proportion of men
1990 to 5.79% in 1999 (p<0.0001). This significant
reported sexual contact/unknown risk (19.8% for men,
decrease in seroprevalence was found for both men
9.8% for women, p<0.0001), whereas a significantly
(p<0.0001) and women (p<0.0001) as well as for white
higher proportion of women reported heterosexual
non-Hispanics, black non-Hispanics, and Hispanics
partner at risk for HIV (9.5% for women, 7.4% for men,
(p<0.0001). Significant downward time trends were
also found among the three race/ethnicity groups when
p<0.0001).
analyzed by gender, except for white non-Hispanic
When compared by race, black non-Hispanics
females (p=0.692).
had significantly (p<0.0001) higher HIV rates for three
of eight risks assessed on the behavioral survey
Figure 1. HIV Seroprevalence among STD clinic clients by race/ethnicity and year.
Miami/Dade County, Florida, 1990-1999
14

White

12

Black

10

Hispanic

8

All Races

6
4
2
0
1990

1991

1992

1993

1994
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The proportion of Hispanics included in the
survey increased from 23% in 1990 to 27% in 1999
(p<0.0001). A significant downward time trend was
observed for black non-Hispanics, with their proportion
decreasing from 68% in 1990 to 63% in 1999
(p<0.0001). The proportion of white non-Hispanics
included also showed a downward time trend,
decreasing from 9% in 1990 to 4% in 1999. With
respect to risk exposure categories, significant
downward trends were observed for the proportion of
IDU only. However, a significant downward trend in
HIV seroprevalence was found for the risk exposure
categories gay/bisexual, and sexual contact/unknown
risk (p<0.001).
Discussion
In this study, the standardized national
protocol facilitates estimation of HIV seroprevalence
among clients attending sexually transmitted disease
clinics. However, data from this survey have several
limitations. First, the data was collected from patients at
increased risk for HIV who chose to seek medical care
at the STD clinic serving this population, and whose
initial visit during an annual survey cycle included
blood collection for routine serologic tests. Therefore,
the patients attending these clinics are not
representative of all persons with STDs (e.g., those seen
by a private physician, those asymptomatic, etc.) and
their seroprevalence data serve as indicators rather than
representative estimates of HIV infection in Miami’s
STD-infected persons. Second, changing patterns of
attendance in STD clinics are a potential source of bias.
For example, HIV-positive patients may be more likely
to seek health care in other medical settings, and thus,
their loss from the STD clinic population could give a
false decreasing prevalence. As counterpoints to
potential sources of bias, the unlinked (blinded) survey
design, the criteria used for the selection of the four
STD clinics, and the high number of participants
strengthen the validity of the results.
HIV Seroprevalence and Risk
Exposure Category
This study corroborates the results of previous
and similar studies. Our study found that HIV infection
rates were higher among those STD clients who
reported behaviors already associated with increased
risk for HIV infection. Among those reporting
heterosexual contact only, the HIV seroprevalence rate
(4.9%) was almost four times the estimated HIV rate
for the Miami-Dade County adult/adolescent population
(1.3%), and about 13 times the national HIV infection
rate of 0.36% (Karon, Rosenberg, McQuillan, Khare,
Gwinn, & Petersen, 1996).
For STD clinic clients reporting one or more
specified risk exposures, HIV seroprevalence rates were
significantly higher than the baseline rate for
Florida Public Health Review, 2005; 2: 73-81
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heterosexual contact only clients.
In particular,
gay/bisexual male, IDU, heterosexual partner at risk for
HIV, and sexual contact/unknown risk were each
associated with highly significant elevations of HIV
seropositivity rates above the baseline heterosexual
rate.
A distinguishing finding of the Miami STD
clinic survey was that there were almost no differences
in seroprevalence noted between men and women for
risk exposure categories when seropositivity rates were
available for both genders. The only exceptions were
the sexual contact/unknown risk category, where the
rate for females was statistically higher than the rate for
males, and the heterosexual contact only category
where the rate for males was higher than the rate for
females. Interestingly, the proportion of women in the
sexual contact/unknown category was statistically
lower than that for men.
Significantly higher rates of HIV infection
were found for black non-Hispanics than for Hispanics
and white non-Hispanics in the following risk exposure
categories: gay/bisexual male, IDU, and sexual
contact/unknown risk. Because the majority of HIVinfected clients reported heterosexual contact only,
further discussion of heterosexual transmission of HIV
among STD patients is warranted. Heterosexual sex is
a prevalent behavior and a significantly higher
proportion of HIV seronegatives (71.9%) reported
heterosexual contact only compared with seropositives
(38.1%, p<0.001). Comparisons presented in Table 3
indicate that all specified sexual and substance use risk
exposures added significant increments to HIV
seroprevalence above the heterosexual contact only.
Finally, the high prevalence of sexually transmitted
diseases among the STD clinic clients who reported
heterosexual contact only enhances sexual transmission
of HIV.
HIV Seroprevalence and Type of STD
Consistent with the concern that STDs
facilitate the transmission of HIV, we hypothesized that
STD clinic clients with non-ulcerative STDs would
have lower HIV seropositivity rates than clients with
ulcerative or multiple STDs. The study results
corroborated these expectations.
Overall and by
gender, we found a statistically significant difference
between the higher seroprevalence rate found in the
multiple STD category and the lower seroprevalence
rates of the ulcerative and non-ulcerative STDs
categories.
A particular characteristic of Miami’s STD
clinic population was the overrepresentation of HIV
seropositive episodes among black non-Hispanic
women in several STD diagnosis categories (vaginal
infections caused by trichomonas, syphilis and genital
ulcers). This is important because of the asymptomatic
nature of many STDs, particularly in the absence of
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regular STD screening. This could result in significant
secondary morbidity (cancer, infertility, ectopic
pregnancy, spontaneous abortions, stillbirth, low birthweight for infants) and higher likelihood of acquiring or
transmitting HIV.
STD prevention and control in public health
settings has focused on surveillance, screening, partner
notification, and treatment. Nevertheless, it is advisable
to put in practice interventions that prevent STDs from
occurring since many are not symptomatic and not
curable. Involvement of the private sector is urgent.
According to the CDC only 5% of those individuals
who reported having been treated for a STD sought care
in a publicly funded STD clinic (Brackbill, Sternberg,
& Fishbein, 1999).
Increasing the number of
professional experts in the field of behavioral and social
sciences at the state and local level would also be
beneficial. If we are to design and implement effective
public health strategies to prevent and control STDs we
need to understand their mode of transmission and the
attached behavioral and cultural attitudes. Finally, the
amount of economic resources allocated to STD
research and prevention should be increased. The costs
of the major STDs - not including HIV infection – and
their complications add at least $10 billion to the
nation’s health care costs each year (Cason, Orrock,
Tesoriero, Lazzarini, & Sumartojo, 2002).
Time Trends: Decreasing HIV
Seroprevalence Over Time
A significant decrease in HIV seroprevalence
was observed over the nine-year survey period from
10.83% in 1990 to 5.79% in 1999. Decreasing trends
have also been observed at the national level (CDC,
2001).
Seeking to understand this drop in
seroprevalence, we noted two significant demographic
shifts toward lower-risk clinic clients: a decreasing
proportion of black non-Hispanic clients, and
increasing proportion of Hispanic and white nonHispanic clients.
The progression of the HIV epidemic and
availability of HIV health services may have led to
some selective “removal” of those at highest risk:
because they died from HIV disease, or entered HIV
treatment trials and/or received medical care elsewhere.
Recommendations for STD Clinics and
Local Health Departments
STD clinics are useful settings for evaluating
HIV prevention programs because they provide services
to patients at increased risk for HIV. They are also an
excellent venue for delivering prevention messages and
conducting STD screening (Backmann, Grimley,
Waithaka, Desmond, Saag, & Hook, 2005).
We strongly agree with the CDC‘s Advisory
Committee on HIV and STD Prevention, in that: (1)
early detection and treatment of curable STDs must be
an integral part of comprehensive HIV prevention
programs; (2) in areas where STDs that facilitate HIV
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transmission are prevalent, screening and treatment
programs should be expanded; and (3) HIV and STD
prevention programs, together with the private and
public sector, should take joint responsibility for
implementing these strategies (CDC, 1998).
Finally, we believe that a strengthened
collaboration between the HIV and STD programs is of
vital importance. In this regard, the CDC’s HIV/STD
Collaboration Workshop has given some useful
recommendations: (1) Share funding and personnel
between STD and HIV; (2) cross-training of staff in
HIV and STD; (3) HIV counseling, testing, and partner
notification made available through the STD program;
and (4) providing referrals to HIV counseling and
testing at local STD clinics (CDC, 1998a).
Public Health Implications
All patients with a STD diagnosis should be
questioned about risk factors for HIV infection.
Whether or not risk factors for HIV are elicited, STD
patients should be urged to have an HIV test performed
because a person with an STD is at increased risk of
HIV infection. Ulcerative STDs facilitate entry for
HIV, and non-ulcerative STDs increase the
concentration of targeting CD4 cells in genital
secretions. Similarly, a person with an STD and HIV
infection may be more infectious. An HIV-infected
patient with another STD is more likely to shed HIV in
their genital secretions than someone who is infected
only with HIV.
Therefore, early diagnosis and treatment of
STDs can reduce both susceptibility to HIV infection,
and infectiousness among those already HIV infected.
Furthermore, confirming a diagnosis of HIV/AIDS
establishes eligibility for certain social, medical, and
economic benefits for the patient.
Conclusion
Among patients treated in Miami-Dade County
STD clinics during the survey period, 7.5% were
infected with HIV. For STD clinic patients reporting
heterosexual contact as the only behavioral risk, 1 in 20
were HIV infected, while for those clients reporting
specific sexual or drug use risks for HIV, the likelihood
of HIV infection increased to 1 in 5. We emphasize the
need for assessing HIV infection in STD patients, and
STD infections in HIV-infected patients.
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